Document is current
Any future updates will be listed below
-
Authors
Lee, Ji Yeon https://orcid.org/0000-0002-2788-1392
Bu, Seon Hee https://orcid.org/0000-0002-5765-3358
Song, EunHyang https://orcid.org/0000-0002-7741-2113
Cho, Seongcheol https://orcid.org/0000-0002-5617-809X
Yu, Sungbong https://orcid.org/0000-0002-1989-6121
Kim, Jungok https://orcid.org/0000-0002-0694-1579
Kym, Sungmin https://orcid.org/0000-0003-3518-966X
Seo, Kwang Won https://orcid.org/0000-0003-0504-6924
Kwon, Ki Tae https://orcid.org/0000-0003-4666-0672
Kim, Jin Yong https://orcid.org/0000-0002-4306-1597
Kim, Sunghyun https://orcid.org/0000-0003-3898-0393
Ahn, Keumyoung https://orcid.org/0000-0002-9370-5338
Jung, Nahyun https://orcid.org/0009-0009-8639-4226
Lee, Yeonmi https://orcid.org/0000-0001-9657-6474
Jung, Yoobin https://orcid.org/0009-0002-8963-1476
Hwang, Chankyoung https://orcid.org/0009-0000-6567-4071
Park, Sang Won https://orcid.org/0000-0002-0550-1897
-
Funding
Funding for this research was provided by:
Celltrion
- License Information
-
More Information
Article History
Received: 26 June 2023
Accepted: 15 August 2023
First Online: 13 October 2023
Declarations
:
: Ji Yeon Lee has been an investigator on COVID-19 clinical trials sponsored by Daewoong Pharmaceuticals, Hyundai Bioscience, Shin Poong Pharmaceutical, and Ildong Pharmaceutical and on an investigator-initiated trial with Celltrion Inc. Seongcheol Cho has been an investigator on a COVID-19 clinical trial sponsored by Shin Poong Pharmaceutical. Jungok Kim and Sungmin Kym have been investigators on COVID-19 trials sponsored by Daewoong Pharmaceuticals, Hyundai Bioscience, Shin Poon Pharmaceutical, Ildong Pharmaceutical, ImmuneMed, Bioleaders, Dong-Wha, Pfizer, Gilead, and Celltrion Inc. Ki Tae Kwon has been an investigator on COVID-19 clinical trials sponsored by GC Holdings, Pfizer, Hyundai Bioscience, APRG Inc., Shin Poong Pharmaceutical, and Ildong Pharmaceutical and on an investigator-initiated trial with Celltrion Inc. Jin Yong Kim has been an investigator on COVID-19 clinical trials sponsored by Daewoong Pharmaceuticals, Enzychem Lifesciences, GC Pharma, Bukwang Pharmaceutical and Pfizer outside the scope of the submitted work, and on an investigator-initiated trial with Celltrion Inc. Sunghyun Kim, Keumyoung Ahn, Nahyun Jung, Yeonmi Lee, Yoobin Jung, and Chankyoung Hwang are employees of Celltrion Inc. Seon Hee Bu, EunHyang Song, Sungbong Yu, and Kwang Won Seo declare no interests related to this article. Sang Won Park has been an investigator on a COVID-19 clinical trial sponsored by Celltrion Inc. Seon Hee Bu was affiliated with Seoul Metropolitan City Bukbu Hospital at the time of the study, and is now affiliated with Kyung Hee University Hospital.
: The study was conducted according to the ethical principles of the Declaration of Helsinki and in compliance with the International Council for Harmonisation Good Clinical Practice and applicable regulatory requirements. The study protocol was approved by the MFDS of the Republic of Korea. Per South Korean laws, additional approval from individual institutional review boards is not required for surveillance studies. All patients provided informed consent.
